SCHEMBL16641215

SCHEMBL16641215

C=CC(=O)Oc1cc2cc3cc(OC(=O)C=C)c(OC(=O)C=C)cc3cc2cc1OC(=O)C=C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ THRB P10828 4/20 0.39
▸ THRA P10827 1/20 0.39
▸ TYMS P04818 1/20 0.37
▸ ALDH1A1 P00352 4/20 0.34
▸ TP53 P04637 3/20 0.34
▸ HSD17B10 Q99714 3/20 0.34
▸ EGFR P00533 3/20 0.34
▸ CYP3A4 P08684 2/20 0.34
▸ KDM4E B2RXH2 2/20 0.34
▸ MAPT P10636 2/20 0.34
▸ HPGD P15428 2/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ PKM P14618 1/20 0.34
▸ ALOX15 P16050 1/20 0.34
▸ ALOX12 P18054 1/20 0.34
▸ JAK1 P23458 1/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ TDP1 Q9NUW8 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16641128 0.85 TYMS (0.41) THRBTHRATYMSALDH1A1TP53
SCHEMBL12245559 0.85 KDM4E (0.52) THRBTHRATYMSALDH1A1TP53
SCHEMBL16641110 0.84 GAPDH (0.38) THRBTHRATYMSALDH1A1TP53
SCHEMBL19999161 0.84 TYMS (0.41) THRBTHRATYMSALDH1A1TP53
SCHEMBL16641068 0.82 GAPDH (0.38) THRBTHRATYMSALDH1A1TP53
SCHEMBL15302744 0.80 THRB (0.50) THRBALDH1A1TP53HSD17B10EGFR
SCHEMBL13538604 0.80 THRB (0.50) THRBALDH1A1TP53HSD17B10EGFR
SCHEMBL15338822 0.77 TYMS (0.41) THRBTHRATYMSALDH1A1HSD17B10
SCHEMBL14417257 0.77 THRB (0.47) THRBTHRATYMSALDH1A1TP53
SCHEMBL14394969 0.77 HTT (0.41) THRBTHRATYMSALDH1A1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9394482-B2 Polymerizable compound, polymerizable composition and liquid crystal display device JNC CORPORATION (JP) 2016-07-19 — — US disclosed
US-9394482-B2 Polymerizable compound, polymerizable composition and liquid crystal display device JNC CORPORATION (JP) 2016-07-19 — — US disclosed
US-20150102259-A1 POLYMERIZABLE COMPOUND, POLYMERIZABLE COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE JNC CORPORATION (JP) 2015-04-16 — — US disclosed
US-20150102259-A1 POLYMERIZABLE COMPOUND, POLYMERIZABLE COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE JNC CORPORATION (JP) 2015-04-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150102259-A1 POLYMERIZABLE COMPOUND, POLYMERIZABLE COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE NCAPD3, LEO1, PYM1 THRB 4873/4885THRA 4835/4885TYMS 4831/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback